Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Cytology for PD-L1 testing: A systematic review.

Gosney JR, Boothman AM, Ratcliffe M, Kerr KM.

Lung Cancer. 2020 Jan 13;141:101-106. doi: 10.1016/j.lungcan.2020.01.010. [Epub ahead of print] Review.

2.

Accelerated instability testing reveals quantitative mass spectrometry overcomes specimen storage limitations associated with PD-L1 immunohistochemistry.

Haragan A, Liebler DC, Das DM, Soper MD, Morrison RD, Slebos RJC, Ackermann BL, Fill JA, Schade AE, Gosney JR, Gruver AM.

Lab Invest. 2020 Jan 2. doi: 10.1038/s41374-019-0366-y. [Epub ahead of print]

PMID:
31896815
3.

Programmed death ligand 1 expression in EBUS aspirates of non-small cell lung cancer: Is interpretation affected by type of fixation?

Gosney JR, Haragan A, Chadwick C, Giles TE, Grundy S, Tippett V, Gumparthy KP, Wight A, Tan HG.

Cancer Cytopathol. 2020 Feb;128(2):100-106. doi: 10.1002/cncy.22216. Epub 2019 Dec 18.

PMID:
31851430
4.

Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response.

Haragan A, Field JK, Davies MPA, Escriu C, Gruver A, Gosney JR.

Lung Cancer. 2019 Aug;134:79-84. doi: 10.1016/j.lungcan.2019.06.005. Epub 2019 Jun 5.

5.

ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question-to treat or not to treat?

Cabillic F, Hofman P, Ilie M, Peled N, Hochmair M, Dietel M, Von Laffert M, Gosney JR, Lopez-Rios F, Erb G, Schalles U, Barlesi F.

ESMO Open. 2018 Sep 17;3(6):e000419. doi: 10.1136/esmoopen-2018-000419. eCollection 2018.

6.

Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer.

Büttner R, Gosney JR, Skov BG, Adam J, Motoi N, Bloom KJ, Dietel M, Longshore JW, López-Ríos F, Penault-Llorca F, Viale G, Wotherspoon AC, Kerr KM, Tsao MS.

J Clin Oncol. 2017 Dec 1;35(34):3867-3876. doi: 10.1200/JCO.2017.74.7642. Epub 2017 Oct 20. Review.

PMID:
29053400
7.

COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancer.

Oleksiewicz U, Liloglou T, Tasopoulou KM, Daskoulidou N, Gosney JR, Field JK, Xinarianos G.

J Cancer Res Clin Oncol. 2017 Jul;143(7):1133-1141. doi: 10.1007/s00432-017-2381-y. Epub 2017 Mar 3.

8.

Aurora B expression modulates paclitaxel response in non-small cell lung cancer.

Al-Khafaji AS, Davies MP, Risk JM, Marcus MW, Koffa M, Gosney JR, Shaw RJ, Field JK, Liloglou T.

Br J Cancer. 2017 Feb 28;116(5):592-599. doi: 10.1038/bjc.2016.453. Epub 2017 Jan 17.

9.

The effect of time changes in diagnosing lung cancer type on its recorded distribution, with particular reference to adenocarcinoma.

Lee PN, Gosney JR.

Regul Toxicol Pharmacol. 2016 Nov;81:322-333. doi: 10.1016/j.yrtph.2016.09.019. Epub 2016 Sep 21. Review.

10.

Left ventricular apical masses: distinguishing benign tumours from apical thrombi.

Kirmani BH, Binukrishnan S, Gosney JR, Pullan DM.

Eur J Cardiothorac Surg. 2016 Feb;49(2):701-3. doi: 10.1093/ejcts/ezv098. Epub 2015 Mar 19.

PMID:
25792148
11.
12.

An unusual cause of multiple pulmonary nodules: glomus tumors of the lung.

Concatto NH, Irion KL, Marchiori E, Gosney JR, Asante-Siaw J, Hochhegger B.

Lung. 2014 Aug;192(4):629-30. doi: 10.1007/s00408-014-9577-6. Epub 2014 Apr 9. No abstract available.

PMID:
24714807
13.

BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas.

Bari MF, Brown H, Nicholson AG, Kerr KM, Gosney JR, Wallace WA, Soomro I, Muller S, Peat D, Moore JD, Ward LA, Freidin MB, Lim E, Vatish M, Snead DR.

Histopathology. 2014 Mar;64(4):547-56. doi: 10.1111/his.12278. Epub 2013 Nov 25.

PMID:
24266897
14.

The impact of positive circumferential margin on survival following oesophagectomy using the new 7th TNM classification.

Theologou T, Diab M, Kyaw PA, Gosney JR, McShane J, Howes N, Page RD, Shackcloth M.

Eur J Cardiothorac Surg. 2013 Nov;44(5):855-9. doi: 10.1093/ejcts/ezt164. Epub 2013 May 5.

PMID:
23650023
15.

Cytoglobin has bimodal: tumour suppressor and oncogene functions in lung cancer cell lines.

Oleksiewicz U, Liloglou T, Tasopoulou KM, Daskoulidou N, Bryan J, Gosney JR, Field JK, Xinarianos G.

Hum Mol Genet. 2013 Aug 15;22(16):3207-17. doi: 10.1093/hmg/ddt174. Epub 2013 Apr 15.

PMID:
23591990
16.

Making light of an interstitial process.

Thahseen A, Williams R, Gosney JR, Menzies D.

Am J Respir Crit Care Med. 2012 Nov 1;186(9):926. doi: 10.1164/rccm.201205-0892IM. No abstract available.

PMID:
23118084
17.

DNA methylation biomarkers offer improved diagnostic efficiency in lung cancer.

Nikolaidis G, Raji OY, Markopoulou S, Gosney JR, Bryan J, Warburton C, Walshaw M, Sheard J, Field JK, Liloglou T.

Cancer Res. 2012 Nov 15;72(22):5692-701. doi: 10.1158/0008-5472.CAN-12-2309. Epub 2012 Sep 7.

18.

Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).

Gosney JR, Williams IJ, Dodson AR, Foster CS.

Histopathology. 2011 Oct;59(4):751-62. doi: 10.1111/j.1365-2559.2011.03992.x.

PMID:
22014055
19.

Neuroglobin and myoglobin in non-small cell lung cancer: expression, regulation and prognosis.

Oleksiewicz U, Daskoulidou N, Liloglou T, Tasopoulou K, Bryan J, Gosney JR, Field JK, Xinarianos G.

Lung Cancer. 2011 Dec;74(3):411-8. doi: 10.1016/j.lungcan.2011.05.001. Epub 2011 Jun 2.

PMID:
21640426
20.

UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer.

Daskalos A, Oleksiewicz U, Filia A, Nikolaidis G, Xinarianos G, Gosney JR, Malliri A, Field JK, Liloglou T.

Cancer. 2011 Mar 1;117(5):1027-37. doi: 10.1002/cncr.25531. Epub 2010 Nov 8.

21.

Large pulmonary masses containing varicose veins: a rare presentation of benign metastasising leiomyomas.

Challa R, Irion KL, Hochhegger B, Shackloth M, Elsayed H, Gosney JR, Binukrishnan S, Marchiori E, Da Silva VC.

Br J Radiol. 2010 Nov;83(995):e243-6. doi: 10.1259/bjr/49938718.

22.

Global DNA hypomethylation-induced ΔNp73 transcriptional activation in non-small cell lung cancer.

Daskalos A, Logotheti S, Markopoulou S, Xinarianos G, Gosney JR, Kastania AN, Zoumpourlis V, Field JK, Liloglou T.

Cancer Lett. 2011 Jan 1;300(1):79-86. doi: 10.1016/j.canlet.2010.09.009.

PMID:
20926182
23.

Inhibition of tumourigenicity of small cell lung cancer cells by suppressing Id3 expression.

Kamalian L, Forootan SS, Bao ZZ, Zhang Y, Gosney JR, Foster CS, Ke Y.

Int J Oncol. 2010 Sep;37(3):595-603.

PMID:
20664928
24.

EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration.

Field JK, Liloglou T, Niaz A, Bryan J, Gosney JR, Giles T, Brambilla C, Brambilla E, Vesin A, Timsit JF, Hainaut P, Martinet Y, Vignaud JM, Thunnissen FB, Prinsen C, Snijders PJ, Smit EF, Sozzi G, Roz L, Risch A, Becker HD, Elborn JS, Magee ND, Montuenga LM, Pajares MJ, Lozano MD, O'Byrne KJ, Harrison DJ, Niklinski J, Cassidy A; EUELC Collaborators.

Eur Respir J. 2009 Dec;34(6):1477-86. doi: 10.1183/09031936.00077809.

25.

Increased expression of Id family proteins in small cell lung cancer and its prognostic significance.

Kamalian L, Gosney JR, Forootan SS, Foster CS, Bao ZZ, Beesley C, Ke Y.

Clin Cancer Res. 2008 Apr 15;14(8):2318-25. doi: 10.1158/1078-0432.CCR-07-4716.

26.

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease.

Davies SJ, Gosney JR, Hansell DM, Wells AU, du Bois RM, Burke MM, Sheppard MN, Nicholson AG.

Thorax. 2007 Mar;62(3):248-52. Epub 2006 Nov 10.

27.

Symptomatic mediastinal myelolipoma.

Mohan K, Gosney JR, Holemans JA.

Respiration. 2006;73(4):552. Epub 2005 Aug 30. No abstract available.

PMID:
16131789
28.
29.

Three different subsite classification systems for carcinomas in the proximity of the GEJ, but is it all one disease?

Dolan K, Morris AI, Gosney JR, Field JK, Sutton R.

J Gastroenterol Hepatol. 2004 Jan;19(1):24-30.

PMID:
14675239
30.

Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays.

Leversha MA, Fielding P, Watson S, Gosney JR, Field JK.

J Pathol. 2003 Aug;200(5):610-9.

PMID:
12898597
31.

Loss of heterozygosity on chromosome 17p predicts neoplastic progression in Barrett's esophagus.

Dolan K, Morris AI, Gosney JR, Field JK, Sutton R.

J Gastroenterol Hepatol. 2003 Jun;18(6):683-9.

PMID:
12753151
32.

In-depth analysis of molecular alterations within normal and tumour tissue from an entire bronchial tree.

Sikkink SK, Liloglou T, Maloney P, Gosney JR, Field JK.

Int J Oncol. 2003 Mar;22(3):589-95.

PMID:
12579312
33.

Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck.

Nunn J, Nagini S, Risk JM, Prime W, Maloney P, Liloglou T, Jones AS, Rogers SR, Gosney JR, Woolgar J, Field JK.

Oral Oncol. 2003 Feb;39(2):115-29.

PMID:
12509964
34.

p53 status correlates with the differential expression of the DNA mismatch repair protein MSH2 in non-small cell lung carcinoma.

Xinarianos G, Liloglou T, Prime W, Sourvinos G, Karachristos A, Gosney JR, Spandidos DA, Field JK.

Int J Cancer. 2002 Sep 20;101(3):248-52.

35.

Terminology and clinicopathological correlation in the idiopathic interstitial pneumonias.

Gosney JR.

Histopathology. 2001 Nov;39(5):540-1. No abstract available.

PMID:
11737316
36.

Cancer-specific genomic instability in bronchial lavage: a molecular tool for lung cancer detection.

Liloglou T, Maloney P, Xinarianos G, Hulbert M, Walshaw MJ, Gosney JR, Turnbull L, Field JK.

Cancer Res. 2001 Feb 15;61(4):1624-8.

37.
38.

hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas.

Xinarianos G, Liloglou T, Prime W, Maloney P, Callaghan J, Fielding P, Gosney JR, Field JK.

Cancer Res. 2000 Aug 1;60(15):4216-21.

39.

Fractional allele loss indicates distinct genetic populations in the development of squamous cell carcinoma of the head and neck (SCCHN).

Nunn J, Scholes AG, Liloglou T, Nagini S, Jones AS, Vaughan ED, Gosney JR, Rogers S, Fear S, Field JK.

Carcinogenesis. 1999 Dec;20(12):2219-28.

PMID:
10590212
40.

Telomerase activity in non-small cell lung carcinomas correlates with smoking status.

Xinarianos G, Scott FM, Liloglou T, Prime W, Callaghan J, Gosney JR, Field JK.

Int J Oncol. 1999 Nov;15(5):961-5.

PMID:
10536180
41.

Creatine kinase-BB isoenzyme in chest pain: an indicator that change in creatine kinase is not always due to an infarct?

Baines M, Gosney JR, Hine TJ, Roberts NB.

Ann Clin Biochem. 1999 Jul;36 ( Pt 4):526-9. No abstract available.

PMID:
10456220
42.

Pulmonary neuroendocrine cells in nitrofen-induced diaphragmatic hernia and the effect of prenatal glucocorticoids.

Gosney JR, Okoye BO, Lloyd DA, Losty PD.

Pediatr Surg Int. 1999;15(3-4):180-3.

PMID:
10370017
43.

Sustentacular cells in pulmonary neuroendocrine tumours.

Gosney JR, Denley H, Resl M.

Histopathology. 1999 Mar;34(3):211-5.

PMID:
10217561
44.

Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer.

Dunn J, Garde J, Dolan K, Gosney JR, Sutton R, Meltzer SJ, Field JK.

Oncogene. 1999 Jan 28;18(4):987-93.

45.
46.

Pulmonary neuroendocrine cell system in pediatric and adult lung disease.

Gosney JR.

Microsc Res Tech. 1997 Apr 1;37(1):107-13. Review.

PMID:
9144627
47.

Pulmonary endocrine cells in anthracosilicotic lungs.

Gosney JR, Peers J, Beesley C, Gradwell E.

Eur Respir J. 1997 Feb;10(2):388-91.

48.

p53 gene aberrations in non-small-cell lung carcinomas from a smoking population.

Liloglou T, Ross H, Prime W, Donnelly RJ, Spandidos DA, Gosney JR, Field JK.

Br J Cancer. 1997;75(8):1119-24.

49.

Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer.

Field JK, Neville EM, Stewart MP, Swift A, Liloglou T, Risk JM, Ross H, Gosney JR, Donnelly RJ.

Br J Cancer. 1996 Dec;74(12):1968-74.

50.

Endocrine cells in tumour-bearing lungs.

Sheard JD, Gosney JR.

Thorax. 1996 Jul;51(7):721-6.

Supplemental Content

Loading ...
Support Center